107 related articles for article (PubMed ID: 1355399)
1. Prognostic significance of the PC10 index as a prospective assay for cervical cancer treated with radiation therapy alone.
Oka K; Hoshi T; Arai T
Cancer; 1992 Sep; 70(6):1545-50. PubMed ID: 1355399
[TBL] [Abstract][Full Text] [Related]
2. Analysis of response to radiation therapy of patients with cervical adenocarcinoma compared with squamous cell carcinoma. MIB-1 and PC10 labeling indices.
Oka K; Nakano T; Hoshi T
Cancer; 1996 Jun; 77(11):2280-5. PubMed ID: 8635096
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic p105 index is an accurate mitotic index, but is not related to prognosis in cervical carcinoma.
Oka K; Nakano T; Arai T
Arch Pathol Lab Med; 1994 May; 118(5):506-9. PubMed ID: 7910727
[TBL] [Abstract][Full Text] [Related]
4. Expression of proliferation-associated antigens in cervical carcinoma: correlations among indexes.
Oka K; Nakano T; Arai T
Pathol Res Pract; 1995 Oct; 191(10):997-1003. PubMed ID: 8838367
[TBL] [Abstract][Full Text] [Related]
5. Transient increases of growth fraction during fractionated radiation therapy for cervical carcinoma. Ki-67 and PC10 immunostaining.
Oka K; Nakano T; Hoshi T
Cancer; 1993 Nov; 72(9):2621-7. PubMed ID: 8402484
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of the PC10 index for patients with stage II and III oesophageal cancer treated with radiotherapy.
Sugahara S; Ohara K; Takahashi A; Irie T; Watanabe T; Tanaka N; Nozawa K; Nakajima K; Itai Y
Acta Oncol; 1999; 38(8):1057-62. PubMed ID: 10665763
[TBL] [Abstract][Full Text] [Related]
7. Proliferating cell nuclear antigen (PCNA) immunostaining--a prognostic factor in ovarian cancer?
Thomas H; Nasim MM; Sarraf CE; Alison MR; Love S; Lambert HE; Price P
Br J Cancer; 1995 Feb; 71(2):357-62. PubMed ID: 7841053
[TBL] [Abstract][Full Text] [Related]
8. Proliferating cell nuclear antigen labeling index of preoperative biopsy specimens in gastric carcinoma with special reference to prognosis.
Maeda K; Chung YS; Onoda N; Kato Y; Nitta A; Arimoto Y; Yamada N; Kondo Y; Sowa M
Cancer; 1994 Feb; 73(3):528-33. PubMed ID: 7905361
[TBL] [Abstract][Full Text] [Related]
9. p53CM1 expression is not associated with prognosis in uterine cervical carcinoma.
Oka K; Nakano T; Arai T
Cancer; 1993 Jul; 72(1):160-4. PubMed ID: 8508400
[TBL] [Abstract][Full Text] [Related]
10. [Comparative study of HPV infection and proliferating cell nuclear antigen of uterine cervix].
Murakami T; Nagai N; Ota S; Ohama K
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Sep; 45(9):967-72. PubMed ID: 8103785
[TBL] [Abstract][Full Text] [Related]
11. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.
Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G
J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607
[TBL] [Abstract][Full Text] [Related]
12. Argyrophilic nucleolar organizer region counts and proliferating cell nuclear antigen scores are two reliable indicators of survival in pharyngeal carcinoma.
Pich A; Chiusa L; Pisani P; Krengli M; Pia F; Navone R
J Cancer Res Clin Oncol; 1992; 119(2):106-10. PubMed ID: 1358893
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of PCNA and cytokeratins for radiation therapy of oral squamous cell carcinoma.
Günzl HJ; Horn H; Schücke R; Donath K
Eur J Cancer B Oral Oncol; 1993 Apr; 29B(2):141-5. PubMed ID: 7514062
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implication of proliferative markers MIB-1 and PC10 in esophageal squamous cell carcinoma.
Lam KY; Law SY; So MK; Fok M; Ma LT; Wong J
Cancer; 1996 Jan; 77(1):7-13. PubMed ID: 8630942
[TBL] [Abstract][Full Text] [Related]
15. Relative changes of MIB1 and PC10 labeling indexes in cell kinetics during radiotherapy for cervical squamous cell carcinoma.
Oka K; Nakano T; Hoshi T
Acta Oncol; 1997; 36(7):749-54. PubMed ID: 9490095
[TBL] [Abstract][Full Text] [Related]
16. [Immunohistochemical study of proliferating cell nuclear antigen (PCNA) in gynecological tumors and their related lesions].
Sawada M; Ueda G; Inoue M; Shimizu H; Ogawa H; Nakazawa A; Fujita M; Tanizawa O; Tsujimoto M
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Feb; 44(2):181-7. PubMed ID: 1347557
[TBL] [Abstract][Full Text] [Related]
17. High growth fraction at 9 grays of radiotherapy is associated with a good prognosis for patients with cervical squamous cell carcinoma.
Oka K; Suzuki Y; Nakano T
Cancer; 2000 Oct; 89(7):1526-31. PubMed ID: 11013367
[TBL] [Abstract][Full Text] [Related]
18. The manifestation of proliferating cell nuclear antigen in adenoid cystic carcinoma.
Kim KH; Chung PS; Rhee CS; Kim WH
Arch Otolaryngol Head Neck Surg; 1994 Nov; 120(11):1221-5. PubMed ID: 7917205
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric characterisation of proliferating cell nuclear antigen using the monoclonal antibody PC10.
Wilson GD; Camplejohn RS; Martindale CA; Brock A; Lane DP; Barnes DM
Eur J Cancer; 1992; 28A(12):2010-7. PubMed ID: 1358156
[TBL] [Abstract][Full Text] [Related]
20. Tissue fixation for immunohistochemical detection of proliferating cell nuclear antigen with PC10 monoclonal antibody.
Casasco A; Casasco M; Cornaglia AI; Danova M; Giordano M; Calligaro A
Biotech Histochem; 1994 Mar; 69(2):112-7. PubMed ID: 7911337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
